FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023683634> ?p ?o ?g. }

• W2023683634 endingPage "e103974" @default.
• W2023683634 startingPage "e103974" @default.
• W2023683634 abstract "Stroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulation monitoring are limiting their use. Apixaban is a novel oral anticoagulant associated with significantly lower hazard rates for stroke, major bleedings and treatment discontinuations, compared to VKAs.To estimate the cost-effectiveness of apixaban compared to VKAs in non-valvular AF patients in the Netherlands.Previously published lifetime Markov model using efficacy data from the ARISTOTLE and the AVERROES trial was modified to reflect the use of oral anticoagulants in the Netherlands. Dutch specific costs, baseline population stroke risk and coagulation monitoring levels were incorporated. Univariate, probabilistic sensitivity and scenario analyses on the impact of different coagulation monitoring levels were performed on the incremental cost-effectiveness ratio (ICER).Treatment with apixaban compared to VKAs resulted in an ICER of €10,576 per quality adjusted life year (QALY). Those findings correspond with lower number of strokes and bleedings associated with the use of apixaban compared to VKAs. Univariate sensitivity analyses revealed model sensitivity to the absolute stroke risk with apixaban and treatment discontinuations risks with apixaban and VKAs. The probability that apixaban is cost-effective at a willingness-to-pay threshold of €20,000/QALY was 68%. Results of the scenario analyses on the impact of different coagulation monitoring levels were quite robust.In patients with non-valvular AF, apixaban is likely to be a cost-effective alternative to VKAs in the Netherlands." @default.
• W2023683634 created "2016-06-24" @default.
• W2023683634 creator A5003738592 @default.
• W2023683634 creator A5016565734 @default.
• W2023683634 creator A5020032394 @default.
• W2023683634 creator A5025387044 @default.
• W2023683634 creator A5062603116 @default.
• W2023683634 creator A5080737514 @default.
• W2023683634 date "2014-08-05" @default.
• W2023683634 modified "2023-10-18" @default.
• W2023683634 title "Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands" @default.
• W2023683634 cites W1985042952 @default.
• W2023683634 cites W1990795953 @default.
• W2023683634 cites W2004102377 @default.
• W2023683634 cites W2021927513 @default.
• W2023683634 cites W2022149251 @default.
• W2023683634 cites W2023143117 @default.
• W2023683634 cites W2031654814 @default.
• W2023683634 cites W2033163507 @default.
• W2023683634 cites W2042505468 @default.
• W2023683634 cites W2044064409 @default.
• W2023683634 cites W2049922379 @default.
• W2023683634 cites W2066157763 @default.
• W2023683634 cites W2073426542 @default.
• W2023683634 cites W2074119210 @default.
• W2023683634 cites W2078092275 @default.
• W2023683634 cites W2083057529 @default.
• W2023683634 cites W2097854437 @default.
• W2023683634 cites W2107424955 @default.
• W2023683634 cites W2111466538 @default.
• W2023683634 cites W2114775432 @default.
• W2023683634 cites W2121695173 @default.
• W2023683634 cites W2123974278 @default.
• W2023683634 cites W2134604454 @default.
• W2023683634 cites W2136489990 @default.
• W2023683634 cites W2136804807 @default.
• W2023683634 cites W2145161475 @default.
• W2023683634 cites W2146289187 @default.
• W2023683634 cites W2148056560 @default.
• W2023683634 cites W2149388786 @default.
• W2023683634 cites W2151074096 @default.
• W2023683634 cites W2161636873 @default.
• W2023683634 cites W2162508946 @default.
• W2023683634 doi "https://doi.org/10.1371/journal.pone.0103974" @default.
• W2023683634 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4122386" @default.
• W2023683634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25093723" @default.
• W2023683634 hasPublicationYear "2014" @default.
• W2023683634 type Work @default.
• W2023683634 sameAs 2023683634 @default.
• W2023683634 citedByCount "22" @default.
• W2023683634 countsByYear W20236836342016 @default.
• W2023683634 countsByYear W20236836342017 @default.
• W2023683634 countsByYear W20236836342018 @default.
• W2023683634 countsByYear W20236836342019 @default.
• W2023683634 countsByYear W20236836342021 @default.
• W2023683634 countsByYear W20236836342022 @default.
• W2023683634 countsByYear W20236836342023 @default.
• W2023683634 crossrefType "journal-article" @default.
• W2023683634 hasAuthorship W2023683634A5003738592 @default.
• W2023683634 hasAuthorship W2023683634A5016565734 @default.
• W2023683634 hasAuthorship W2023683634A5020032394 @default.
• W2023683634 hasAuthorship W2023683634A5025387044 @default.
• W2023683634 hasAuthorship W2023683634A5062603116 @default.
• W2023683634 hasAuthorship W2023683634A5080737514 @default.
• W2023683634 hasBestOaLocation W20236836341 @default.
• W2023683634 hasConcept C126322002 @default.
• W2023683634 hasConcept C127413603 @default.
• W2023683634 hasConcept C2776301958 @default.
• W2023683634 hasConcept C2778661090 @default.
• W2023683634 hasConcept C2779161974 @default.
• W2023683634 hasConcept C2780638905 @default.
• W2023683634 hasConcept C2780645631 @default.
• W2023683634 hasConcept C71924100 @default.
• W2023683634 hasConcept C78519656 @default.
• W2023683634 hasConceptScore W2023683634C126322002 @default.
• W2023683634 hasConceptScore W2023683634C127413603 @default.
• W2023683634 hasConceptScore W2023683634C2776301958 @default.
• W2023683634 hasConceptScore W2023683634C2778661090 @default.
• W2023683634 hasConceptScore W2023683634C2779161974 @default.
• W2023683634 hasConceptScore W2023683634C2780638905 @default.
• W2023683634 hasConceptScore W2023683634C2780645631 @default.
• W2023683634 hasConceptScore W2023683634C71924100 @default.
• W2023683634 hasConceptScore W2023683634C78519656 @default.
• W2023683634 hasIssue "8" @default.
• W2023683634 hasLocation W20236836341 @default.
• W2023683634 hasLocation W20236836342 @default.
• W2023683634 hasLocation W20236836343 @default.
• W2023683634 hasLocation W20236836344 @default.
• W2023683634 hasLocation W20236836345 @default.
• W2023683634 hasLocation W20236836346 @default.
• W2023683634 hasOpenAccess W2023683634 @default.
• W2023683634 hasPrimaryLocation W20236836341 @default.
• W2023683634 hasRelatedWork W1907038671 @default.
• W2023683634 hasRelatedWork W1972269502 @default.
• W2023683634 hasRelatedWork W1993190469 @default.
• W2023683634 hasRelatedWork W2006773714 @default.
• W2023683634 hasRelatedWork W2021252689 @default.
• W2023683634 hasRelatedWork W2108745446 @default.

• next